The Pacific Northwest is one mass tragedy away from a blood supply crisis. Nicolas Cage’s Car Collection Is More Than A ...

Columnist Oluwatosin Adesoye describes her childhood with the constipation that can come with sickle cell, as well as how she ...

Here in the Pacific Northwest, the situation is no different. We’re one mass-tragedy away from a blood supply crisis, ...

The underutilization of disease-modifying therapy by people with sickle cell disease is “persistent and alarming,” according ...

Sickle cell anemia, also called drepanocytosis, is a blood disorder or hemoglobin disorder that changes the shape of red blood cells. The abnormally shaped red blood cells interfere with the delivery ...

One of the reasons of anemia can be Sickle Cell Anemia (SCA)—a genetic blood disorder where the body produces red blood cells that are abnormally shaped.” Also read | Sickle cell disease ...

A groundbreaking new gene therapy for sickle cell patients is now being rolled out for use on the NHS in England, as ITV News' Health Correspondent Rebecca Barry reports A £1.65 million treatment ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...

Would the transplant work? What would it look like to have a successful stem cell transplant? Would it be a cure for my sickle cell disease? It was a decision I could think about making because my ...

A gene-editing therapy that offers a “functional cure” for some sickle cell patients has been approved for use on the NHS in England, in a move heralded as a positive “leap” forward. The National ...

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.